February 18, 2026
Rose
Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
from NYT > Health https://ift.tt/cyLW4k6
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment